Detalhe da pesquisa
1.
RAS/RAFlandscape in monoclonal plasma cell conditions.
Blood
; 2024 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643494
2.
Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor.
Blood
; 141(11): 1308-1315, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36375118
3.
Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical features.
Blood
; 139(17): 2666-2672, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35171994
4.
Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study.
Blood
; 139(18): 2747-2757, 2022 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511184
5.
Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world: The retrospective IMAGE study.
Eur J Haematol
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712850
6.
Combining thrombopoietin receptor agonists with immunosuppressive drugs in adult patients with multirefractory immune thrombocytopenia, an update on the French experience.
Br J Haematol
; 202(4): 883-889, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37247631
7.
Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experience.
Blood
; 138(25): 2686-2695, 2021 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34479366
8.
del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma.
Blood
; 137(9): 1192-1195, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33080624
9.
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.
Haematologica
; 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38031755
10.
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.
Am J Hematol
; 98(2): 264-271, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588407
11.
Lamotrigine in mood disorders: Flash survey on prescribing habits and blood tests practices.
Encephale
; 49(6): 640-644, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246103
12.
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(10): 1378-1390, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34529931
13.
Oral therapy adherence and satisfaction in patients with multiple myeloma.
Ann Hematol
; 100(7): 1803-1813, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33938996
14.
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.
Lancet
; 394(10192): 29-38, 2019 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31171419
15.
A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.
Haematologica
; 104(1): 138-146, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30171024
16.
Safety of intrathecal route: focus to methylprednisolone acetate (Depo-Medrol) use.
Eur Spine J
; 28(1): 21-30, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29151132
17.
VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trial.
Blood
; 127(21): 2569-74, 2016 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27002117
18.
Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma.
Blood
; 128(25): 2941-2948, 2016 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27729323
19.
Preliminary hazard analysis applied to outsourcing sterile chemotherapy preparations.
J Oncol Pharm Pract
; : 1078155218785239, 2018 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29933726
20.
Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?
Blood
; 126(25): 2713-9, 2015 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26516228